Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

R. Cantón, M. Akóva, Y. Carmeli, C. G. Giske, Y. Glupczynski, M. Gniadkowski, D. M. Livermore, V. Miriagou, T. Naas, G. M. Rossolini, [No Value] Samuelsen, H. Seifert, N. Woodford, P. Nordmann, L. Poirel, P. Bogaerts, S. Navon-Venezia, G. Cornaglia

Research output: Contribution to journalArticle

Abstract

Plasmid-acquired carbapenemases in Enterobacteriaceae, which were first discovered in Europe in the 1990s, are now increasingly being identified at an alarming rate. Although their hydrolysis spectrum may vary, they hydrolyse most β-lactams, including carbapenems. They are mostly of the KPC, VIM, NDM and OXA-48 types. Their prevalence in Europe as reported in 2011 varies significantly from high (Greece and Italy) to low (Nordic countries). The types of carbapenemase vary among countries, partially depending on the cultural/population exchange relationship between the European countries and the possible reservoirs of each carbapenemase. Carbapenemase producers are mainly identified among Klebsiella pneumoniae and Escherichia coli, and still mostly in hospital settings and rarely in the community. Although important nosocomial outbreaks with carbapenemase-producing Enterobacteriaceae have been extensively reported, many new cases are still related to importation from a foreign country. Rapid identification of colonized or infected patients and screening of carriers is possible, and will probably be effective for prevention of a scenario of endemicity, as now reported for extended-spectrum β-lactamase (mainly CTX-M) producers in all European countries.

Original languageEnglish
Pages (from-to)413-431
Number of pages19
JournalClinical Microbiology and Infection
Volume18
Issue number5
DOIs
Publication statusPublished - May 2012

Fingerprint

Enterobacteriaceae
Scandinavian and Nordic Countries
Lactams
Carbapenems
Greece
Klebsiella pneumoniae
Italy
Disease Outbreaks
Hydrolysis
Plasmids
Escherichia coli
carbapenemase
Population

Keywords

  • Carbapenemases
  • Cross-border transmission
  • Enterobacteriaceae
  • Europe
  • Extended-spectrum β-lactamases
  • Polyclonal spread

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Cantón, R., Akóva, M., Carmeli, Y., Giske, C. G., Glupczynski, Y., Gniadkowski, M., ... Cornaglia, G. (2012). Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clinical Microbiology and Infection, 18(5), 413-431. https://doi.org/10.1111/j.1469-0691.2012.03821.x

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. / Cantón, R.; Akóva, M.; Carmeli, Y.; Giske, C. G.; Glupczynski, Y.; Gniadkowski, M.; Livermore, D. M.; Miriagou, V.; Naas, T.; Rossolini, G. M.; Samuelsen, [No Value]; Seifert, H.; Woodford, N.; Nordmann, P.; Poirel, L.; Bogaerts, P.; Navon-Venezia, S.; Cornaglia, G.

In: Clinical Microbiology and Infection, Vol. 18, No. 5, 05.2012, p. 413-431.

Research output: Contribution to journalArticle

Cantón, R, Akóva, M, Carmeli, Y, Giske, CG, Glupczynski, Y, Gniadkowski, M, Livermore, DM, Miriagou, V, Naas, T, Rossolini, GM, Samuelsen, NV, Seifert, H, Woodford, N, Nordmann, P, Poirel, L, Bogaerts, P, Navon-Venezia, S & Cornaglia, G 2012, 'Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe', Clinical Microbiology and Infection, vol. 18, no. 5, pp. 413-431. https://doi.org/10.1111/j.1469-0691.2012.03821.x
Cantón, R. ; Akóva, M. ; Carmeli, Y. ; Giske, C. G. ; Glupczynski, Y. ; Gniadkowski, M. ; Livermore, D. M. ; Miriagou, V. ; Naas, T. ; Rossolini, G. M. ; Samuelsen, [No Value] ; Seifert, H. ; Woodford, N. ; Nordmann, P. ; Poirel, L. ; Bogaerts, P. ; Navon-Venezia, S. ; Cornaglia, G. / Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. In: Clinical Microbiology and Infection. 2012 ; Vol. 18, No. 5. pp. 413-431.
@article{2705fba26c4d418aaa63fc8330b28200,
title = "Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe",
abstract = "Plasmid-acquired carbapenemases in Enterobacteriaceae, which were first discovered in Europe in the 1990s, are now increasingly being identified at an alarming rate. Although their hydrolysis spectrum may vary, they hydrolyse most β-lactams, including carbapenems. They are mostly of the KPC, VIM, NDM and OXA-48 types. Their prevalence in Europe as reported in 2011 varies significantly from high (Greece and Italy) to low (Nordic countries). The types of carbapenemase vary among countries, partially depending on the cultural/population exchange relationship between the European countries and the possible reservoirs of each carbapenemase. Carbapenemase producers are mainly identified among Klebsiella pneumoniae and Escherichia coli, and still mostly in hospital settings and rarely in the community. Although important nosocomial outbreaks with carbapenemase-producing Enterobacteriaceae have been extensively reported, many new cases are still related to importation from a foreign country. Rapid identification of colonized or infected patients and screening of carriers is possible, and will probably be effective for prevention of a scenario of endemicity, as now reported for extended-spectrum β-lactamase (mainly CTX-M) producers in all European countries.",
keywords = "Carbapenemases, Cross-border transmission, Enterobacteriaceae, Europe, Extended-spectrum β-lactamases, Polyclonal spread",
author = "R. Cant{\'o}n and M. Ak{\'o}va and Y. Carmeli and Giske, {C. G.} and Y. Glupczynski and M. Gniadkowski and Livermore, {D. M.} and V. Miriagou and T. Naas and Rossolini, {G. M.} and Samuelsen, {[No Value]} and H. Seifert and N. Woodford and P. Nordmann and L. Poirel and P. Bogaerts and S. Navon-Venezia and G. Cornaglia",
year = "2012",
month = "5",
doi = "10.1111/j.1469-0691.2012.03821.x",
language = "English",
volume = "18",
pages = "413--431",
journal = "Clinical Microbiology and Infection",
issn = "1198-743X",
publisher = "Elsevier B.V.",
number = "5",

}

TY - JOUR

T1 - Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

AU - Cantón, R.

AU - Akóva, M.

AU - Carmeli, Y.

AU - Giske, C. G.

AU - Glupczynski, Y.

AU - Gniadkowski, M.

AU - Livermore, D. M.

AU - Miriagou, V.

AU - Naas, T.

AU - Rossolini, G. M.

AU - Samuelsen, [No Value]

AU - Seifert, H.

AU - Woodford, N.

AU - Nordmann, P.

AU - Poirel, L.

AU - Bogaerts, P.

AU - Navon-Venezia, S.

AU - Cornaglia, G.

PY - 2012/5

Y1 - 2012/5

N2 - Plasmid-acquired carbapenemases in Enterobacteriaceae, which were first discovered in Europe in the 1990s, are now increasingly being identified at an alarming rate. Although their hydrolysis spectrum may vary, they hydrolyse most β-lactams, including carbapenems. They are mostly of the KPC, VIM, NDM and OXA-48 types. Their prevalence in Europe as reported in 2011 varies significantly from high (Greece and Italy) to low (Nordic countries). The types of carbapenemase vary among countries, partially depending on the cultural/population exchange relationship between the European countries and the possible reservoirs of each carbapenemase. Carbapenemase producers are mainly identified among Klebsiella pneumoniae and Escherichia coli, and still mostly in hospital settings and rarely in the community. Although important nosocomial outbreaks with carbapenemase-producing Enterobacteriaceae have been extensively reported, many new cases are still related to importation from a foreign country. Rapid identification of colonized or infected patients and screening of carriers is possible, and will probably be effective for prevention of a scenario of endemicity, as now reported for extended-spectrum β-lactamase (mainly CTX-M) producers in all European countries.

AB - Plasmid-acquired carbapenemases in Enterobacteriaceae, which were first discovered in Europe in the 1990s, are now increasingly being identified at an alarming rate. Although their hydrolysis spectrum may vary, they hydrolyse most β-lactams, including carbapenems. They are mostly of the KPC, VIM, NDM and OXA-48 types. Their prevalence in Europe as reported in 2011 varies significantly from high (Greece and Italy) to low (Nordic countries). The types of carbapenemase vary among countries, partially depending on the cultural/population exchange relationship between the European countries and the possible reservoirs of each carbapenemase. Carbapenemase producers are mainly identified among Klebsiella pneumoniae and Escherichia coli, and still mostly in hospital settings and rarely in the community. Although important nosocomial outbreaks with carbapenemase-producing Enterobacteriaceae have been extensively reported, many new cases are still related to importation from a foreign country. Rapid identification of colonized or infected patients and screening of carriers is possible, and will probably be effective for prevention of a scenario of endemicity, as now reported for extended-spectrum β-lactamase (mainly CTX-M) producers in all European countries.

KW - Carbapenemases

KW - Cross-border transmission

KW - Enterobacteriaceae

KW - Europe

KW - Extended-spectrum β-lactamases

KW - Polyclonal spread

UR - http://www.scopus.com/inward/record.url?scp=84859913969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859913969&partnerID=8YFLogxK

U2 - 10.1111/j.1469-0691.2012.03821.x

DO - 10.1111/j.1469-0691.2012.03821.x

M3 - Article

C2 - 22507109

AN - SCOPUS:84859913969

VL - 18

SP - 413

EP - 431

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

SN - 1198-743X

IS - 5

ER -